---
title: "Allogene Therapeutics (ALLO.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/ALLO.US/norm.md"
symbol: "ALLO.US"
name: "Allogene Therapeutics"
parent: "https://longbridge.com/zh-HK/quote/ALLO.US.md"
datetime: "2026-05-21T03:40:32.540Z"
locales:
  - [en](https://longbridge.com/en/quote/ALLO.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ALLO.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ALLO.US/norm.md)
---

# Allogene Therapeutics (ALLO.US) — 財務報表

## 損益表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.1773 | -0.1717 | -0.1865 | -0.2327 | -0.2774 |
| ROE | -59.65% | -51.08% | -50.19% | -55.83% | -59.17% |
| 營業收入 | - | - | - | - | - |
| 凈利潤 | -42.61M | -38.81M | -41.40M | -50.94M | -59.73M |
| 營業利潤 | -46.09M | -42.40M | -44.90M | -54.44M | -65.19M |
| 毛利率 | - | - | - | - | - |
| 凈利率 | - | - | - | - | - |
| 利潤含金量 | - | - | - | - | - |

## 資產負債表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 395.96M | 415.90M | 439.77M | 470.59M | 507.98M |
| 權益乘數 | 1.42 | 1.42 | 1.39 | 1.37 | 1.32 |
| 每股凈資產 | 1.14 | 1.28 | 1.41 | 1.57 | 1.76 |
| 資產周轉率 | - | - | 0.0000 | 0.0000 | 0.0000 |
| 現金及短投 | 266.89M | 250.21M | 252.19M | 273.12M | 280.04M |
| 存貨與應收 | - | - | - | - | - |
| 長期投資 | 108.84M | 112.73M | 116.83M | 120.82M | 127.07M |
| 凈債務 | -185.84M | -166.96M | -167.05M | -186.12M | -191.12M |

## 現金流量表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | -12.91M | -27.60M | -29.69M | -39.03M | -52.93M |
| 投資現金流 | -29.59M | 33.61M | 11.94M | 43.84M | 6.18M |
| 融資現金流 | 21.12M | 7.86M | 3.24M | 5.07M | 13.99M |
| 自由現金流 | -20.94M | -13.85M | -15.64M | -18.75M | -31.82M |
| 現金流充裕率 | -143477.78% | - | -12217.28% | -88704.55% | -53463.64% |
| 舉債與償債 | - | - | - | - | - |
| 資本支出 | -9000.00 | 0.0000 | -243000.00 | -44000.00 | -99000.00 |